Literature DB >> 19120516

Renal cell carcinoma with a huge solitary metastasis to the contralateral adrenal gland: a case report.

Takanobu Utsumi1, Hiroyoshi Suzuki, Kazuyoshi Nakamura, Woojin Kim, Shuichi Kamijima, Yusuke Awa, Kazuhiro Araki, Naoki Nihei, Yukio Naya, Tomohiko Ichikawa.   

Abstract

Renal cell carcinoma (RCC) is capable of metastasizing to several organs. Synchronous isolated contralateral adrenal metastasis of the primary RCC is, however, very rare. Herein we report a case of RCC with a huge solitary metastasis to the contralateral adrenal gland that was surgically treated. We scheduled nephrectomy for the left primary RCC and adrenalectomy for the right adrenal tumor. However, at surgery we found a huge right adrenal tumor that had invaded the right kidney, right renal vein, and inferior vena cava. Therefore right nephrectomy was performed simultaneously with resection and reconstruction of the inferior vena cava. Pathological findings demonstrated that the left renal tumor and right adrenal tumor had the same histology. Although the patient required hemodialysis, he remains well at six months postoperatively. So far, there have been only two cases of a solitary contralateral metastatic adrenal tumor that was larger than the primary RCC, thus the present case is the third one.

Entities:  

Mesh:

Year:  2008        PMID: 19120516     DOI: 10.1111/j.1442-2042.2008.02182.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  2 in total

1.  Renal cell carcinoma with double synchronous contralateral adrenal metastases.

Authors:  Masanori Ishida; Kaoru Kojima; Kuni Ohtomo
Journal:  Korean J Urol       Date:  2010-12-21

2.  Renal cell carcinoma with metachronous metastasis to the contralateral adrenal gland and urinary bladder: A case report.

Authors:  Kai Wang; Junkai Wang; J I Sun; Dachuan Zhong; Shengcheng Tai; Danfeng Xu; Y I Fan
Journal:  Oncol Lett       Date:  2015-09-18       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.